The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.
While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.
The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.
To that end, HHS has granted Moderna $590 million to help accelerate the development of a bird flu vaccine. The agency announced its backing of the Massachusetts-based pharmaceutical firm about ...
Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...
All nine macaques given the control developed severe disease when exposed to bird flu, as did all given the smallest dose of ...
Bird flu has decimated poultry flocks and infected cattle herds. The risk to humans is currently low, but that could easily ...